Skip to main content
Premium Trial:

Request an Annual Quote

TurboBlast, BioRS Integration and Retrieval System, GenBank Release 123.0, Delta2D.

Premium

TurboGenomics of New Haven, Conn., has released the latest version of TurboBlast, an accelerated, parallel implementation of the Blast sequence comparison tool.

TurboBlast partitions Blast computations into manageable tasks and distributes them across a network of workstations, PCs, or Macs. Additional machines can be added to the system for greater speed-up.

Biomax Informatics, based in Martinsried, Germany, has released version 4.0 of the BioRS Integration and Retrieval System, which gives users access to multiple biological data sources, including in-house proprietary databases.

BioRS 4.0 simplifies the creation and integration of new relational databases by allowing users to copy the format of an existing relational database. The new release will also allow users to execute searches using phrases with all indexed fields, refining queries for more relevant search results.

GenBank Release 123.0 is now available from the National Center for Biotechnology Information at the ftp site, ncbi.nlm.nih.gov.

The new release contains 12,418,544,023 base pairs and 11,545,572 entries. In the eight-week period between close-of-data for GenBank 122.0 and GenBank 123.0, GenBank grew by 698 million basepairs and 648,791 sequence records.

A GenBank mirror site is also available at ftp://genbank.sdsc.edu/pub.

Version 1.1 of Delta2D, analysis software for 2D electrophoresis gels, is now available from Greifswald, Germany-based Decodon.

Delta2D uses image processing algorithms that bypass manual correction steps for spot detection and spot matching. Version 1.1 offers freely definable color schemes, which provide extended analysis capabilities and individual designed presentations.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.